Table 2. Cox regression analysis for the overall survival of NSCLC patients with SPC occurrence at different period.
| SPC or not | Event (%) | HR | 95% CI | P |
|---|---|---|---|---|
| No SPC | 170,174 (75.2) | – | – | – |
| SPC at different time interval | ||||
| 0–6 months | 4,439 (67.2) | 0.883 | 0.857–0.910 | 0.000 |
| 0–12 months | 5,209 (66.6) | 0.858 | 0.834–0.882 | 0.000 |
| 0–36 months | 7,229 (63.6) | 0.751 | 0.734–0.769 | 0.000 |
| 0–60 months | 8,389 (61.4) | 0.689 | 0.674–0.705 | 0.000 |
| 0–120 months | 9,122 (59.2) | 0.629 | 0.615–0.642 | 0.000 |
NSCLC, non-small cell lung cancer; SPC, second primary cancer; HR, hazard ratio; CI, confidence interval.